GRI Bio, Inc.

As of May 27, 2025, the market trend is mildly bearish due to daily moving averages indicating bearish momentum, despite some bullish signals from the weekly MACD and RSI, suggesting caution amid mixed signals.

GRI Bio, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $3.19 million. Key financial metrics indicate it is not profitable, with a negative return on equity and no dividend yield.

As of Jun 18, GRI Bio, Inc. has a market capitalization of 3.19 million, classifying it as a Micro Cap company, with net sales of 0.00 million and a net profit of -9.37 million over the latest four quarters. As of Dec'24, the company reported shareholder's funds of 4.03 million and total assets of 5.74 million.